LexDanaLexDanabeta
Inventor

CHRISTIAN LEISNER

Inventor
CH

Overview

2→
Patents
2024–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms13%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
PatentTitleYear
12,344,663Anti-C3 antibodies and antigen-binding fragments thereof and their uses for treating eye or ocular diseases202512,146,187Methods of treating dry eye disease using TNF alpha antagonists2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024Patents assigned to NOVARTIS AG (1)· patent assignee history
2024–2025Based in CH· patent location history
2025Patents assigned to BOEHRINGER INGELHEIM INT (1)· patent assignee history
2025Patents assigned to CDR LIFE AG (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BOEHRINGER INGELHEIM INT12025
CDR LIFE AG12025
NOVARTIS AG12024
Locations
LocationPatentsSpan
CH22024–2025